MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
DCPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Deciphera Pharmaceuticals (DCPH) Ownership - Who owns Deciphera Pharmaceuticals?

Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
200 Smith Street
Phone
+1 781 209-6400
Employees
355
Web
https://www.deciphera.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.27B
P/E Ratio
N/A
Total Cash
306.22M
Projected Growth
N/A
Total Debt
25.88M
Revenue
163.36M
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
3.79
Total Debt/Equity
N/A
Revenue/Share
1.92 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for DCPH
A.I. Advisor
published General Information

General Information

a developer of novel drug candidates to improve the lives of cancer patients

Industry PharmaceuticalsOther

Profile
Details
Industry
Biotechnology
Address
200 Smith Street
Phone
+1 781 209-6400
Employees
355
Web
https://www.deciphera.com